Breaking News

Neuraxpharm expands operations in Switzerland

The company has appointed Jörg Gärtner as Country Manager for Switzerland

How to stay up-to-date with pharmaceutical developments?

Subscribe to Manufacturing Chemist magazine today!

Neuraxpharm expands its business in Southeast Europe

Headquartered in Athens, Brain Therapeutics specialises in the in-licensing and commercialisation of pharmaceutical products in the CNS therapy area

Cold chain predictions: creating a new normal in 2022

At this time last year, the world was eagerly anticipating 2021. COVID-19 vaccines delivered hope for normalcy and excitement grew regarding conven...

Ferrer and United Therapeutics sign distribution agreement

The agreement covers exclusive distribution rights for United Therapeutics’ treprostinil inhalation solution for pulmonary hypertension associated...

Thermo Fisher launches CGT packaging and distribution service

Patheon commercial packaging services for cell and gene therapies (CGT) combines GMP storage, serialisation, ultracold and cryogenic packaging, as...

The pros and cons of distribution agreements

For life sciences companies seeking to break into overseas markets, distribution agreements are central to success

Tekni-Plex enters into distributor agreement with PackPlus

“Demand by local medical device manufacturers for breathable sterilisable materials that meet the most stringent quality standards continues to ris...

Barentz to acquire Maroon Group

The acquisition is expected to close later this quarter

Macsa ID agrees strategic partnership with Codetronix

The businesses will serve the UK’s food, beverage, pharmaceutical, personal care and cosmetics industries

Sanofi and GSK to supply 72m COVID vaccine doses to Canada

Agreements relate to vaccine candidate using Sanofi’s recombinant protein-based technology and GSK’s pandemic adjuvant